GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Opsens Inc (TSX:OPS) » Definitions » EV-to-EBIT

Opsens (TSX:OPS) EV-to-EBIT : -28.55 (As of May. 26, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Opsens EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Opsens's Enterprise Value is C$326.57 Mil. Opsens's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 was C$-11.44 Mil. Therefore, Opsens's EV-to-EBIT for today is -28.55.

The historical rank and industry rank for Opsens's EV-to-EBIT or its related term are showing as below:

TSX:OPS' s EV-to-EBIT Range Over the Past 10 Years
Min: -1576.35   Med: -14.98   Max: 252.37
Current: -28.55

During the past 13 years, the highest EV-to-EBIT of Opsens was 252.37. The lowest was -1576.35. And the median was -14.98.

TSX:OPS's EV-to-EBIT is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 20.17 vs TSX:OPS: -28.55

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Opsens's Enterprise Value for the quarter that ended in Aug. 2023 was C$222.00 Mil. Opsens's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 was C$-11.44 Mil. Opsens's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Aug. 2023 was -5.15%.


Opsens EV-to-EBIT Historical Data

The historical data trend for Opsens's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opsens EV-to-EBIT Chart

Opsens Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -42.05 -39.95 -669.57 -28.98 -19.47

Opsens Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.98 -18.15 -14.61 -12.02 -19.47

Competitive Comparison of Opsens's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Opsens's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Opsens's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Opsens's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Opsens's EV-to-EBIT falls into.



Opsens EV-to-EBIT Calculation

Opsens's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=326.573/-11.439
=-28.55

Opsens's current Enterprise Value is C$326.57 Mil.
Opsens's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-11.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Opsens  (TSX:OPS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Opsens's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Aug. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Aug. 2023 ) =EBIT / Enterprise Value (Q: Aug. 2023 )
=-11.439/221.997
=-5.15 %

Opsens's Enterprise Value for the quarter that ended in Aug. 2023 was C$222.00 Mil.
Opsens's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-11.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Opsens EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Opsens's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Opsens (TSX:OPS) Business Description

Traded in Other Exchanges
N/A
Address
750, Boulevard du Parc-Technologique, Quebec, QC, CAN, G1P 4S3
OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. It operates in two segments that are Medical and Industrial. In Medical segment it supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices. Industrial segment includes developing, manufacturing and installing fibre optic sensing solutions for industrial applications. Majority of its revenue is derived from Medical segment.
Executives
Alan Milinazzo Director
Robin Villeneuve Senior Officer
Fiera Capital Corporation (formerly Fiera Sceptre Inc.) 10% Security Holder

Opsens (TSX:OPS) Headlines

No Headlines